180 related articles for article (PubMed ID: 33963721)
21. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
[TBL] [Abstract][Full Text] [Related]
22. [Role of protein phosphatase 2A in renal interstitial fibrosis].
Xi Y; Li H; Li J; Li Y; Liu Y; You Y; Duan S; Liu H; Sun L; Peng Y; Liu F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 40(6):569-78. PubMed ID: 26164503
[TBL] [Abstract][Full Text] [Related]
23. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
24. [The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS].
Dou XR; Yu XQ; Li XY; Chen WF; Hao WK; Jia ZJ; Peng WX; Wang X; Yin PD; Wang WJ; Zheng ZH
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2613-8. PubMed ID: 16321321
[TBL] [Abstract][Full Text] [Related]
25. Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.
Liu KH; Zhou N; Zou Y; Yang YY; OuYang SX; Liang YM
Med Sci Monit; 2019 Dec; 25():9346-9356. PubMed ID: 31812978
[TBL] [Abstract][Full Text] [Related]
26. MiR-200a ameliorates peritoneal fibrosis and functional deterioration in a rat model of peritoneal dialysis.
Wei X; Bao Y; Zhan X; Zhang L; Hao G; Zhou J; Chen Q
Int Urol Nephrol; 2019 May; 51(5):889-896. PubMed ID: 30888602
[TBL] [Abstract][Full Text] [Related]
27. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
[TBL] [Abstract][Full Text] [Related]
28. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells.
Ha H; Yu MR; Lee HB
Kidney Int; 2001 Feb; 59(2):463-70. PubMed ID: 11168928
[TBL] [Abstract][Full Text] [Related]
29. The effects of Panax notoginseng saponins on the cytokines and peritoneal function in rats with peritoneal fibrosis.
Hu W; Zhang Y; Sigdel KR
Ren Fail; 2015; 37(9):1507-13. PubMed ID: 26371362
[TBL] [Abstract][Full Text] [Related]
30. Caffeic acid phenethyl ester restores mitochondrial homeostasis against peritoneal fibrosis induced by peritoneal dialysis through the AMPK/SIRT1 pathway.
Lu Y; Gao L; Zhang W; Zeng Y; Hu J; Song K
Ren Fail; 2024 Dec; 46(1):2350235. PubMed ID: 38721924
[TBL] [Abstract][Full Text] [Related]
31. Suramin inhibits the development and progression of peritoneal fibrosis.
Xiong C; Liu N; Fang L; Zhuang S; Yan H
J Pharmacol Exp Ther; 2014 Nov; 351(2):373-82. PubMed ID: 25168661
[TBL] [Abstract][Full Text] [Related]
32. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
33. Newly designed Protein Transduction Domain (PTD)-mediated BMP-7 is a potential therapeutic for peritoneal fibrosis.
Kim S; Shin DH; Nam BY; Kang HY; Park J; Wu M; Kim NH; Kim HS; Park JT; Han SH; Kang SW; Yook JI; Yoo TH
J Cell Mol Med; 2020 Nov; 24(22):13507-13522. PubMed ID: 33079436
[TBL] [Abstract][Full Text] [Related]
34. Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.
Musi B; Braide M; Carlsson O; Wieslander A; Albrektsson A; Ketteler M; Westenfeld R; Floege J; Rippe B
Perit Dial Int; 2004; 24(1):37-47. PubMed ID: 15104335
[TBL] [Abstract][Full Text] [Related]
35. Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats.
Zhu F; Li T; Qiu F; Fan J; Zhou Q; Ding X; Nie J; Yu X
Am J Pathol; 2010 Feb; 176(2):650-9. PubMed ID: 20056840
[TBL] [Abstract][Full Text] [Related]
36. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.
Li L; Shen N; Wang N; Wang W; Tang Q; Du X; Carrero JJ; Wang K; Deng Y; Li Z; Lin H; Wu T
Kidney Int; 2018 Jun; 93(6):1384-1396. PubMed ID: 29571940
[TBL] [Abstract][Full Text] [Related]
37. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor.
Li X; Liu H; Sun L; Zhou X; Yuan X; Chen Y; Liu F; Liu Y; Xiao L
J Cell Mol Med; 2019 Apr; 23(4):2372-2383. PubMed ID: 30693641
[TBL] [Abstract][Full Text] [Related]
39. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
40. Low molecular weight heparin (LMWH) improves peritoneal function and inhibits peritoneal fibrosis possibly through suppression of HIF-1α, VEGF and TGF-β1.
Li J; Guo ZY; Gao XH; Bian Q; Jia M; Lai XL; Wang TY; Bian XL; Wang HY
PLoS One; 2015; 10(2):e0118481. PubMed ID: 25723475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
